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Abstract:
Objective: To determine whether silver sulfadiazine (SSD) should remain the gold standard of
initial burn wound treatment or if it should be replaced with an alternative treatment that allows
for faster skin cell regrowth. Methods: Database search of PubMed and Google Scholar were
used to evaluate patient clinical trials with the search terms “burn”, “honey”, and “silver”.
Results: Three trials met inclusion criteria. All three of the studies found significant
improvement in their primary endpoint with the use of honey. The first study showed the honey
group to have healing time of 13.47 + 4.06 days and SSD group 15.62 + 4.40 days (p-value <
0.0001).8 The second study showed the honey group to have a healing time of 18.1 + 2.3 days
and SSD group 32.6 + 3.6 days (p-value <0.05).9 The third study showed the honey group to
have a healing time of 11.41 + 3.95 days, where the SSD group was 15.25 + 5.92 days (p-value
0.0049).10 Conclusion: This systematic review shows moderate evidence in support of using
medical-grade honey as the gold standard for initial antimicrobial treatment for superficial
partial-thickness burn wounds. However, until additional randomized, double-blinded studies
comparing standardized honey products with SSD with more subjects within a smaller age range
exist, we cannot recommend or discourage the use of honey over SSD.
Introduction:
Burns are a major cause of morbidity and mortality worldwide. According to the World
Health Organization, burns contribute to 180,000 deaths each year and are a leading cause of
prolonged hospitalization, disfigurement, and disability.1 Burns are classified by total body
surface area (TBSA) and their depth. Superficial burns extend into the epidermis, partialthickness burns extend into the epidermis and dermis, and full-thickness burns extend further
into the subcutaneous fat or deeper.2
Even though burns have such a significant impact on lives worldwide, there is no
universally accepted treatment choice for burn wound healing. For the past 40 years, the gold
standard conservative treatment of burn wounds has been silver sulfadiazine 1% (SSD). SSD is a
chemical-based cream that is applied to a fine mesh that covers burns. The exact mechanism of
action of SSD is unknown, but it is thought that it disrupts the bacterial wall and prevents
colonization of both gram-positive and gram-negative organisms.3 Well-controlled studies have

BOWLER AND DIAMOND

found SSD to decrease bacterial colonization of burn wounds, but there is little evidence that
shows the efficacy when it comes to wound healing and decreased infection.4
Although SSD has antimicrobial properties, the extent to which it promotes epithelial
regrowth and reduces infection is questionable. Pseudoeschar, produced by SSD, may promote
bacteria around the edges of a burn wound, which can lead to an increase in infection.5 Another
adverse side effect is that the bactericidal properties of SSD are non-specific and may kill
healthy, rapidly reproducing cells, such as keratinocytes and fibroblasts. These cells are
necessary for re-epithelialization, therefore their destruction delays wound healing time.6 The
efficiency and speed of re-epithelialization is a priority for burn wound patients, therefore the
gold standard of wound dressings should be reconsidered.
There are many alternatives to silver sulfadiazine for superficial partial thickness burns
that are currently being researched. One of those alternatives is medical grade honey, a substance
that has been used for millennia, which has found yet another use. Honey has been shown to
have antimicrobial effects against both gram-negative and gram-positive bacteria without the
same toxic effects on tissue as SSD.7 Honey, therefore, may lead to faster rates of reepithelialization of burn wounds because its mechanism of action does not have a cytotoxic
effects directed towards non-bacterial organisms. This meta-analysis aims to determine whether
honey, in comparison to silver sulfadiazine, improves wound healing in partial thickness burns.
Clinical Question:
In patients with superficial partial-thickness burns (second degree), does honey as
compared to silver sulfadiazine increase the re-epithelialization (rate of skin cell regrowth) at the
wound site (Table 1).
Table 1: PICO criteria for clinical question.
Population

Superficial and partial thickness burn patients

Intervention

Honey

Comparison

Silver sulfadiazine

Outcome

Increased rate of re-epithelialization of the
wound site
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Methods:
An initial search started with PubMed and Google Scholar using search terms “burn”,
“honey”, and “silver”. PubMed resulted in 24 articles and Google Scholar resulted in 1 article
(Figure 1). The 25 articles were screened and excluded 18 articles due to them being systematic
reviews, not full-text, and not published within the past 10 years. This narrowed our search to 7
full-text articles, which were reviewed. Four articles were excluded because silver sulfadiazine
was not used as the control and the outcomes measured were only bacterial levels. Ultimately,
three articles were chosen because they were the only articles that focused on the comparison
between honey and silver sulfadiazine, and their effect on wound healing in partial thickness
burns.

Figure 1. Prisma flow diagram.
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Results:
Study #1: Honey compared with silver sulfadiazine in the treatment of superficial partialthickness burns8
Study Objective:
The objective of this study was to evaluate the ability of honey to create an environment
in which superficial and partial-thickness burn wounds can re-epithelialize faster in comparison
to silver sulfadiazine.
Study Design:
This clinical trial occurred at Burn Center POF Hospital, Wah Cantt, Pakistan, from May
2007 to February 2008. Patients were included in the trial if they had burns within 24 hours
before initiation of treatment, two burns at the same site, classified as second degree burns, and
total burn surface area (TBSA) < 40%. Patients were excluded if they had diabetes,
immunodeficiency, pregnancy, kidney disease, or electrical and chemical burns. All inclusion
and exclusion criteria are summarized in Table 2.
Table 2. Patient Inclusion and Exclusion criteria for Study 1.8
Inclusion Criteria
Burns occurred within 24 hours before initiation of treatment
Two burns at the same site (i.e. on feet or hands, right or left side of abdomen/chest, etc.)
Second degree burn
Burn <40% TBSA
Exclusion Criteria
Diabetes
Immunodeficiency
Pregnancy
Kidney disease
Electrical and chemical burns
Patients were informed of the honey treatment and written informed consent was
obtained. There were 150 patients that enrolled in this study. All patients were treated with fluid
resuscitation, daily dressings, and treatment protocols set by the hospital. The burns were cleaned
with water or normal saline, and the topical agent Langnese honey or SSD cream was applied on
the wound in different areas. For example, a left burned hand was treated with honey and a right
burned hand was treated with SSD in the same patient. The ‘A’ part of the body was treated with

BOWLER AND DIAMOND

honey, and the ‘B’ part of the body was treated with SSD. The dressing was changed and honey
was applied twice daily. Topical treatment was continued until the burns were fully healed and
epithelialized.
A wound swab was taken after 2 weeks. At each time of dressing change, the wound was
evaluated for any signs of infection, size, and the rate and nature of epithelization by a surgeon.
The patients and nursing staff were blinded to the procedure. The width and length of the wound
was measured with a ruler and photographed, and then multiplied to calculate the area in
centimeters. The healing percentage and healing were recorded. Healing percentage = [(area of
first day - area of second time)/(area at first time)] x 100.
Study Results:
Based on the 150 patients assigned to either honey or SSD treatment, the mean times for
healing were 15.62 +/- 4.40 and 13.47 +/- 4.06 days for SSD and honey respectively. Times for
healing were significantly shorter for honey (P < 0.0001). Wounds treated with honey healed 2
days sooner than the wounds treated with SSD on average in all patients. In the group treated
with honey, wound healing took less than 20 days in 93% of sites, while healing took more than
24 days in sites treated with SSD.
Additionally, the surfaces of both wound sites were tested for microbial contamination.
Six patients whose wounds were treated with honey were found to be positive for Pseudomonas
at their wound sites. However, SSD sites showed positive cultures for Pseudomonas in 27
patients, and two more patients had Escherichia coli infections at their wound sites.
Table 3. Results of Healing Time for Honey group and SSD group.8
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Study Critique:
A strength of this article was the fact that patients acted as their own control. This
eliminated the need to match patients in case and control groups, which is a major limitation of
other studies. Another strength was that the nurses and patients were blinded to the treatment.
A limitation of this study is the difference in initial cleaning of the wound with either
saline or water. This difference in initial would cleaning could have led to a difference in reepithelialization, which could have skewed results. Also, there was no standardization in the
wound evaluation. The study did not specify whether all of the evaluations were performed by a
single surgeon, or if it would multiple surgeons. This could have led to discrepancies in whether
there were signs of infection and the rate and nature of epithelialization.
Study #2: Honey dressing versus silver sulfadiazine dressing for wound healing in burn
patients: A retrospective study9
Study Objective:
The objective of this study was to evaluate the effect of honey dressing and SSD dressing
on wound healing in burn patients.
Study Design:
The study retrospectively reviewed the records of 108 patients (ages 14- 68) with first
and second degree burns of less than 50% of the total body surface area. Data were collected
over a period of 5 years (2004-2008) from patients who were admitted to the department of
surgery at MGM Medical College and MY Hospital in Indore, Madhya Pradesh, India. Patients
were excluded if they were in an immunocompromised state, had signs of organ failure, and if
they were on chemotherapy at the time. Inclusion and exclusion criteria for this study is
summarized in table 3.
Table 4. Patient Inclusion and Exclusion criteria for Study 2.9
Inclusion Criteria
Burns treated with honey dressings or silver sulfadiazine
First and second degree burns with less than 50% TBSA
Exclusion Criteria
Immunocompromised state
Any organ failure
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Currently on chemotherapy
Patients were divided into two groups: “honey group” and “silver sulfadiazine group”
depending on which topical agent they received at the time of their admission. Swabs of the
wounds were taken on admission and again after 7 days of treatment. Patients in the “honey
group” were treated with pure undiluted honey, meanwhile patients in the “silver sulfadiazine
group” were treated with SSD cream. Both groups were treated with topical agents daily.
The outcome criteria were determined by the completeness of wound healing. A
complete recovery was indicated by wound area without any scar or contracture of the skin. Any
formation of a scar or sign of contracture was not determined to be a successful final outcome.
Study Results:
The patients were stratified and compared in regards to their sex, degree of burn,
percentage of burns, and time to report. The Mann-Whitney test compared patient’s sex and
degree of burn, which showed no significance. The Pearson’s Chi-square test compared the
TBSA and time to report, which showed no statistical significance, except that more patients
from the “honey group” presented within the first 8 hours.
The average wound healing duration in the “honey group” coming within 1, 1-8, 9-24,
25-48, and more than 48 hours were 18.8, 17.8, 21.25, and 14.25 days, respectively. Among the
patients in the “SSD group” coming within 1, 1-8, 9-48, and more than 48 hours their healing
times were 27.6, 32.4, 32.5, and 38.5 days, respectively. The average healing duration of the
“honey group” (18.1 days, SD = 2.3) was significantly lower than that of patients in the “SSD
group” (32.6 days, SD = 3.6; p<0.05). Results are shown in Table 4.
Table 5. Time elapsed after burns until reporting and healing times with treatment.9
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Among the 41 patients treated with honey dressings who reported within 24 hours, 32
patients had a complete recovery while 9 had incomplete. Two of these nine patients progressed
to third degree burns. Out of the total 51 patients treated with honey, 41 had a complete recovery.
Among 42 patients treated with SSD who reported within 24 hours, 17 patients had a complete
recovery, and out the total 57 patients, only 27 achieved a complete recovery. Three of these
patients progressed to third degree burns. The difference between the honey treatment and SSD
treatment were statistically significant (p = 0.002). Results are shown in Table 5.
Table 6. Final Outcome in Honey group and SSD group.9

Study Critique:
A strength of this study was the strict criteria used for complete burn wound healing.
Burns treated with either honey or SSD were only considered to be completely healed if there
were no signs of scarring or contracture.
Limitations of this study include the large age range of subjects. The subjects ranged
from pediatric patients to geriatric patients, and all adults that fall between those extremes.
Another limitation was that the study was done retrospectively. This means the researchers did
not choose the subjects’ treatment nor administration protocol. Another limitation of this study
was that first degree burns were included in the study, which is not necessary since those burns
do not break the skin barrier. A final limitation is the time of publication of this article. It is
possible that more research has been done specifically on either honey or silver sulfadiazine in
wound care.
Study #3: Effects of silver sulfadiazine and Actilite® honey on bacteria wound colonisation and
wound healing in children with partial superficial burn wounds at University Teaching Hospital,
Lusaka, Zambia10
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Study Objective:
The objective of this study was to examine the effects of Actilite Honey and Silver
Sulfadiazine on bacteria wound colonization and wound healing in pediatric partial superficial
burn wounds.
Study Design:
This study is an open label randomized controlled study that was conducted from August,
2017 to February, 2018 at the University Teach Hospital, Lusaka, Zambia. Inclusion criteria
included patients to be under 12 years of age, sustained < 20% partial superficial burn wounds,
and presented within 24 hours of the injury. Patients who sustained inhalation burns, were HIV
positive, or malnourished were excluded from the study. Inclusion and exclusion criteria for this
study is summarized in Table 6.
Table 7. Patient Inclusion and Exclusion criteria for Study 3.10
Inclusion Criteria
Under the age of 12
Sustained <20% partial superficial burn wounds
Presented within 24 hours of injury
Exclusion Criteria
Inhalation burns
HIV positive
Malnourished
Patients were allocated into the Actilite honey group and SSD group via simple
randomization. Numbers 1 to 100 were placed into a box, and the guardians of the patients were
asked to draw a number. The even number was treated with honey, while the odd number was
treated with SSD. At enrollment of the study, documentation of the patient’s sex, age, TBSA,
burn agent, and time to hospital (hrs) was recorded. The burnt surface area was evaluated weekly
for one month using 1cm2 transparent graft until there was 95% re-epithelialization. Wounds
were cleaned daily with soap and water, then dressed with Flazine (SSD from Shalina
Pharmaceuticals, Zambia) or Actilite honey (Advancis Medicals, UK), then secondarily dressed
with crepe bandages. In between wound changings, pethidine was given IM to ease the pain.
Statistical analysis was performed on the two pharmaceutical companies that provided
SSD and honey for this study. Data entered into Microsoft Excel and analyzed using SPSS 22.0.
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Clinical moments were compared using t-test for continuous variables with normal distribution,
and chi-squared was categorical variables.
Study Results:
64 patients were enrolled in this study over a 7 month period (07/08/17-02/10/18). 32
patients were allocated to each the honey group and the SSD group. Three patients died prior to
full reepithelialization of their wounds and a per-protocol analysis was performed.
Two main outcomes were measured in this study: wound colonization over a 10 day
period and time taken for wounds to reach full reepithelialization. For the purpose of this
systematic review, we will focus only on the data supporting time to reach full
reepithelialization. The mean duration for wounds to attain full reepithelialization was 11 +/- 4 in
the honey group and 15 +/- 6 days in the silver sulfadiazine group. A student T-test was
performed and the results showed that honey was superior to SSD (P=0.0049) at 95% confidence
level (Table 8).
Table 8. Statistical Analysis of Average Days to reach full reepithelialization.10

Study Critique:
A strength of this study is that it was randomized; however, since SSD was donated by a
pharmaceutical as a paste and the honey donated as a dressing, there was no way to blind the
study. This lack of blinding is a limitation of the study due to the potential for bias. Another
strength of this study was that the groups were homogenous in regards to baseline characteristics
(age, gender, type of burn), so it was suitable for comparison in the studied outcome. Another
limitation noted in this study was the lack of stringent inclusion and exclusion criteria. Also, the
admission of patients into general wards could have led to cross contamination, which ultimately
could have led to increased bacterial colonization and decreased epithelialization of the wounds.
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Discussion
This review focused on comparing the differences in efficacy between honey and silver
sulfadiazine in the reepithelialization of partial thickness burns. The current studies conflict on
whether honey should be first line treatment for burns. Table 9 summarizes the results of the
systematically reviewed studies.
Table 9. Summary of Studies.10
Study 1
Malik, et. al.8

Study 2
Gupta, et. al.9

Study 3
Zulu, et. al.10

Objective

Evaluate the efficacy of
honey in the treatment of
superficial and partialthickness burns covering less
than 40% of body surface
area and to compare its
results with those of silver
sulfadiazine.

Evaluate the effect of
honey dressing and SSD
dressing on wound healing
burn patients.

Examine the effects of
Actilite Honey and Silver
Sulfadiazine on bacteria
wound colonization and
wound healing in pediatric
partial thickness burn
wounds of 20% total body
surface area.

Study Type

Clinical trial

Retrospective study

Open label randomized trial

Sample Size

n= 150

n= 108 (41, 57)

n= 64 (32, 32)

Country

Pakistan

India

Zambia

Ages

12-44 yo

14-68 yo

<12 yo

Conclusion

The average healing time for
the honey group was 13.47 +
4.06 days, where the SSD
group was 15.62 + 4.40 days
(p-value < 0.0001).

The average healing time
for the honey group was
18.1 + 2.3 days, where the
SSD group was 32.6 + 3.6
days (p-value <0.05).

The average healing time for
the honey group was 11.41 +
3.95 days, where the SSD
group was 15.25 + 5.92 days
(p-value 0.0049).

The three studies reviewed were similar in some aspects, however there were some big
differences noted between them. A similarity between all the studies is that they consistently use
of SSD as a control and honey as the independent variable. Another similarity between the
studies is that there was statistical significance between honey and SSD in the healing time of
burns.
The biggest difference between the studies was that they were different study types. This
difference in study type makes it difficult to group the results together and make a final
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conclusion. Also, since there were no double blinded randomized control studies, there could
have been bias and confounding variables in the studies. Another difference noticed between the
studies was the lack of conformity in the type of honey used. The study done by Malik, et. al.
used Langnese honey and the study done by Zulu, et. al. used Actilite honey, while the study
done by Gupta, et. al. didn’t specify the type of honey used. Other differences noted between the
studies was the difference in ages studied and the location of the studies (Table 9).
A weakness of this systematic review is the sample size of the three articles included. It is
hard to consider strength of studies by normal standards when investigating a topic such as
burns. Most studies do not have large samples of subjects due to the nature of the injury. Each
study considered in this systematic review also had strict inclusion criteria that revolved around
patients with partial thickness burns. This means that an already small population is narrowed
down even further.
A strength of this review is that each study agreed that SSD is not the optimal choice for
burn care. Each study was intended to determine whether or not an alternative antimicrobial
could be more efficacious in decreasing bacterial colonization in burns wound and therefore
allowing a more stable environment to promote reepithelialization. All of the studies had similar
inclusion criteria when it came to the extent of burn injury (partial thickness). Therefore, Malik,
et al. was determined to have the greatest amount of limitations of the three studies, while Zulu,
et al. is believed to be the most reliable.
There are limitations of this systematic review due to the heterogeneity between the three
studies with regards to the inclusion of pediatric subjects, the wide age range of subjects, and the
honey agent of choice. Specifically, Zulu, et al. investigated the burn wound healing of only
pediatric patients younger than 12 years old while Malik, et al. and Gupta, et al. each studied
subjects within the range of 12-68 years old. In general, pediatric patients tend to heal faster than
adults and geriatric patients regardless of disease type. Also, each of the three studies used
different brands of medical-grade topical honey agents. While the honey treatment groups all
showed faster reepithelialization time compared to SSD, it is difficult to determine the
superiority of a specific honey product because the different honey products were not compared
to each other.
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Overall, additional large randomized controlled double blind studies on the effectiveness
of honey compared to SSD are necessary to determine its benefits and decreased
reepithelialization rate for burn wounds.
Conclusion
This systematic review does not show strong evidence in the use of honey on partial
thickness burns. Even though there was statistical evidence that showed honey improved healing
time in all the studies reviewed, due to the small sample size, large range of ages, and lack of
randomized double-blinded controlled studies it was determined that the use of honey can neither
be supported nor discouraged to treat burn wounds. The honey agents used in these studies only
represent a few of the honey products that exist today. Several common trademarks of medicalgrade honey products available for use (Activon, HoneySoft, Manuka Health, Medihoney,
MelMax, MelDra, L-Mesitran, etc.). Honey has broad-spectrum antimicrobial properties that are
strong against approximately 80 species of microorganisms that colonize in burns wounds such
as gram positive and gram negative bacteria, aerobes and anaerobes, some fungal species of
Aspergillus and Penicillium, and more11. The differences between the currently marketed honey
agents is still unclear, and finding a maximally beneficial agent would be more likely if future
studies only centered on one honey product.
Future research should focus on using standardized honey product, same age range,
degree of burn, blind patients and providers from the treatment/control group, and attempt to
increase the sample size. It is apparent that SSD should no longer be the first line use in the
treatment of burns, so it is critical to push for research in order to determine a new first-line
treatment that is cost effective, safe, and optimizes healing time for burn patients.
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